Skip to main content
. 2015 Mar 5;10(3):e0118845. doi: 10.1371/journal.pone.0118845

Fig 5. Effect of NNK and beta-adrenoceptors on the expression p-ERK1/2, cyclin-D1, Bcl-2, VEGF, and Bax.

Fig 5

NNK promoted the expression of p-ERK1/2, cyclin-D1, Bcl-2, and VEGF, and decreased the expression of Bax in KYSE410 (A) and HET-1A (B) cells. Knockdown of beta-adrenoceptors decreased the expression of p-ERK1/2, cyclin D1, Bcl-2, and VEGF, and increased the expression of Bax. More importantly, down-regulation of both beta1- and beta2-adrenoceptors before treatment with NNK reversed the NNK-associated protein expression, and beta2-adrenoceptors showed a more significant effect. Beta-actin served as an endogenous control. Independent experiments were repeated three times. Negative is representative of nonspecific control siRNA for beta-adrenoceptors.